A trade mark’s reputation is beside the point in an infringement claim alleging deceptive similarity, the Full Federal Court heard Monday in an appeal of a case involving two of Australia’s biggest meat processing and distribution companies.
E-retailer Catch Group has sued competitor Kogan, saying the online retailer is violating its “catch” trademarks and the consumer law through sponsored links on Google driven by phrases using the word “catch”.
A 64-year-old woman has sued Virgin Australia over injuries allegedly sustained as a result of a bumpy landing on a domestic flight.
Fresh off a win in its first race discrimination case, the Fair Work Ombudsman has issued a warning to employers that discriminate against workers on the basis of race: we will come after you.
A judge has vacated a trial scheduled to start next week in Melbourne between the ACCC and NIB Health Funds over claims the health insurer violated consumer protection laws by making changes to its plans without first notifying members.
The Queensland Supreme Court has frozen more than $200 million in personal assets of mining tycoon and former MP Clive Palmer, in a case brought by the liquidators of failed Queensland Nickel.
The Full Federal Court on Friday dismissed an appeal of a ruling that barred a labour hire company from entering into an enterprise agreement with a small group of employees that covered a larger, more diverse workforce.
A technology company has won dismissal of a Federal Court case alleging its industrial machine safety system that uses laser beams to detect hazards infringed on a patent licensed to a rival.
A Federal Court judge on Friday reluctantly approved a $12 million settlement in the long-running class action against Bank of Queensland, saying it left almost nothing for those affected by the notorious Sherwin Ponzi scheme.
In a major loss for the ACCC, the Full Federal Court on Friday tossed the competition regulator’s challenge to a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.